Xiangfei Shi

SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitors.

J. Martini, J. Nuss, Wentao Zhang, 2012, Bioorganic & medicinal chemistry letters.

3,3-Dimethyl-1H-pyrrolo[3,2-g]quinolin-2(3H)-one derivatives as novel Raf kinase inhibitors

Yanyang Li, Yanjin Zhao, Shuxin Li, 2013 .

A rapid approach to capture the potential bioactive compounds from Rhizoma Drynariae, utilizing disease-associated mutation in calcium sensing receptor to alter the binding affinity for agonists.

Xiangfei Shi, Meizhi Jiao, Ru Xu, 2023, Journal of pharmaceutical and biomedical analysis.

Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonists.

Aaron Shipway, L. Mattheakis, J. Nuss, 2012, Journal of medicinal chemistry.